Phase 1/2a clinical trials of MVA-based H5N1 vaccine

Joost H C M Kreijtz, Marco Goeijenbier, Fleur M Moesker, Lennert van den Dries, Simone Goeijenbier, Heidi L M De Gruyter, Michael H Lehmann, Gerrie de Mutsert, David A M C van de Vijver, Asisa Volz, Ron A M Fouchier, Eric C M van Gorp,  Guus F Rimmelzwaan, Gerd Sutter, Albert D M E Osterhaus (2014) Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trialThe Lancet Infectious Diseases in press (corrected proof) DOI: 10.1016/S1473-3099(14)70963-6